Deal Details
STEMCELL Completes Debt Recapitalization
Summary
STEMCELL Technologies (“STEMCELL” or the “Company”) recently completed a recapitalization through a new senior secured term loan and revolving credit facility. The Company intends to use the proceeds to repay existing indebtedness, finance growth expenditures and fund working capital and other general corporate purposes.
Baird served as the exclusive debt advisor to STEMCELL Technologies on this transaction
About
STEMCELL is Canada’s largest biotechnology company. The Company develops specialized cell culture media, cell isolation systems, and accessory solutions that are used by life sciences researchers working in the cell therapy, cancer research, and regenerative medicine fields. STEMCELL provides high-quality scientific tools to clients worldwide, serving more than 100 countries. STEMCELL is privately owned and headquartered in Vancouver, Canada.CONTACT US TO LEARN MORE
- Date
- July 2019
- Company
- STEMCELL Technologies
- Transaction
- Private Capital Markets
- Sectors
- Healthcare
- Verticals
-
Biotechnology & Pharmaceuticals
- Target Geography
- North America
Share
